Primary Ciliary Dyskinesia in a Portuguese Bronchiectasis Outpatient Clinic

Genes (Basel). 2023 Feb 21;14(3):541. doi: 10.3390/genes14030541.

Abstract

Primary ciliary dyskinesia (PCD) is a rare hereditary condition characterized by decreased mucociliary clearance of the airways and a compromised reproductive system, resulting in male and female infertility. Several mutations with varied clinical and pathological features have been documented, making diagnosis a challenging process. The purpose of this study is to describe the clinical and pathological features of Portuguese patients with PCD and to examine their genetic variants. A retrospective observational analysis was conducted with patients who were being monitored at a bronchiectasis outpatient clinic in 2022 and had a confirmed or high-likelihood diagnosis of PCD. In total, 17 patients were included in the study, with 12 (66.7%) having PCD confirmed and 5 (29.4%) having a high-likelihood diagnosis. Furthermore, 12 patients were subjected to transmission electron microscopy (TEM), with 7 (58.3%) exhibiting one hallmark defect. Genetic test data was obtained for all 17 patients, with 7 of them (41.2%) displaying a pathogenic/likely pathogenic mutation in homozygosity. To summarize, PCD is an uncommon but significant hereditary illness with consequences regarding morbidity and mortality. Despite the lack of a specific treatment, it is critical to confirm the diagnosis with genetic testing in order to effectively manage the disease and its accompanying disorders.

Keywords: ciliary function; genetics; next-generation sequencing; primary ciliary dyskinesia; transmission electron microscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchiectasis* / diagnosis
  • Bronchiectasis* / genetics
  • Ciliary Motility Disorders* / diagnosis
  • Ciliary Motility Disorders* / genetics
  • Female
  • Genetic Testing
  • Humans
  • Male
  • Portugal
  • Retrospective Studies

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The UMIB-Unit for Multidisciplinary Research in Biomedicine is funded by the Foundation for Science and Technology (FCT) Portugal (grant numbers UIDB/00215/2020 and UIDP/00215/2020) and ITR-Laboratory for Integrative and Translational Research in Population Health (LA/P/0064/2020).